SARS-CoV-2 Seroprevalence in Western Romania, March to June 2021

<i>Background and Objectives:</i> The extent of SARS-CoV-2 infection among a population may be assessed by the presence of serum SARS-CoV-2 antibodies, which indicates previous exposure. The aim of this study was to determine the seroprevalence of SARS-CoV-2 infection in the adult popula...

Full description

Bibliographic Details
Main Authors: Tudor Rares Olariu, Alina Cristiana Craciun, Daliborca Cristina Vlad, Victor Dumitrascu, Iosif Marincu, Maria Alina Lupu
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/58/1/35
Description
Summary:<i>Background and Objectives:</i> The extent of SARS-CoV-2 infection among a population may be assessed by the presence of serum SARS-CoV-2 antibodies, which indicates previous exposure. The aim of this study was to determine the seroprevalence of SARS-CoV-2 infection in the adult population from Western Romania. <i>Materials and Methods:</i> Samples of 2443 consecutive individuals, referred for routine laboratory investigations, were tested for SARS-CoV-2 antibodies using the Elecsys immunoassay that targets the nucleocapsid protein, for identifying the presence of the total antibodies against SARS-CoV-2. <i>Results:</i> The overall SARS-CoV-2 seroprevalence was 45.60%. SARS-CoV-2 seroprevalence was significantly higher in age group 30–49 years (53.94%) compared to age groups 50–69 years (43.53%) and 70–91 years (30.79%) (<i>p</i> < 0.001, <i>p</i> < 0.001, respectively). No significant difference in seroprevalence was observed between females (44.83%) and males (47.05%). <i>Conclusions:</i> Our data revealed a high seroprevalence of SARS-CoV-2 infection in the adult population from Western Romania and indicate the rapid and significant spread of the virus. The estimated prevalence of 45.60% was 6 times higher than the rate of confirmed COVID-19 cases reported in the study area. This indicates the magnitude of virus transmission in the community.
ISSN:1010-660X
1648-9144